Research conducted that pertains to medical practices should not be used to benefit or advance pharmaceutical profits. If experiments determine that medication will cause a harmful health risk to patients, they should not be distributed for public availability. The ethical standards held at the BigPharma Corporation are of little value when it comes to marketing and profits (Perry, 2011). According to uglybusiness.org (2000-2013), BigPharma should be ashamed of their tactics and greed and should be utilizing the results of their studies for the greater good of humanity. Though examination results returned with negative and harmful side effects, BigPharma neglected the risky damage that patients could possibly suffer from and marketed the product in hopes of financial gain. BigPharma
According to Cooper and Schindler (2011), business research and other information sources provides an understanding of how information drives decisions relating to organizational mission, goals, strategies, and tactics. “As in other aspects of business, all parties in research should exhibit ethical behavior” (Cooper & Schindler, 2011). “The goal of ethics in research is to ensure that no one is harmed or suffers adverse consequences from research activities” (Cooper & Schindler, 2011). The commitment to provide service to others should be based on an honesty policy that does not mislead or withhold information that could affect another’s health or safety. Though BigPharma had an ethics policy established, along with a code of conduct, they did not follow the criteria or guidelines that were set forth in those regulations. Myhr (2011) believes that although BigPharma’s experiments with certain drugs proved to be harmful, they still marketed certain pharmaceuticals and allowed them to be available to the public. The Harm
BigPharma patents and formulates a mass production of harmful drugs that they have confirmed through research poses a detrimental threat to...
Please join StudyMode to read the full document